Is aggressive surgery in pleural empyema justified?

Area of Science:

• Thoracic Surgery
• Infectious Diseases
• Critical Care Medicine

Background:

• Pleural empyema management often involves concerns about high risk and prolonged hospitalization with aggressive surgical approaches.
• Conservative treatments for pleural empyema can be unsuccessful, necessitating more invasive interventions.

Purpose of the Study:

• To evaluate the outcomes and duration of hospitalization for patients with pleural empyema treated with an aggressive surgical schedule.
• To assess the efficacy and safety of aggressive surgical intervention in severe pleural empyema cases.

Main Methods:

• Retrospective analysis of 101 patients with pleural empyema treated since 1989.
• Surgical interventions included thoracotomy (n=85), wedge resection/lobectomy/pneumonectomy (n=29), open-window thoracostomy (n=22), and drainage/irrigation (n=16).
• Patients presented with varying stages of empyema, including metapneumonic and post-traumatic/surgical, with many having failed prior conservative treatments or being critically ill.

Main Results:

• The overall mortality rate was 3.9% (4/101 patients), with deaths attributed to sepsis or unrelated complications.
• The median duration of hospitalization was 14 days (mean 21.1 days).
• Most patients successfully resumed their preoperative activities following treatment.

Conclusions:

• Aggressive surgical management of pleural empyema, particularly beyond the seropurulent stage, effectively resolves sepsis.
• This approach demonstrates a low mortality rate, even in critically ill patients with advanced empyema.
• Aggressive surgery can lead to shorter hospitalization and successful patient recovery.